Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pet Pharm Biotech CoROCO:7762 +0.20%19 Dividend Yield % is 0.50% as of Jul. 21, 2026, which is 92% above its 10-year median of 0.26. GuruFocus rates ROCO:7762 with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 513 Drug Manufacturers companies, Pet Pharm Biotech Co ranks worse than 95.32% on this metric.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Pet Pharm Biotech Co is 0.50%.
The historical rank and industry rank for Pet Pharm Biotech Co's Dividend Yield % or its related term are showing as below:
ROCO:7762'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.13 Med: 0.26 Max: 0.5
Current: 0.5
During the past 4 years, the highest Dividend Yield of Pet Pharm Biotech Co was 0.50%. The lowest was 0.13%. And the median was 0.26%.
ROCO:7762's Dividend Yield % is ranked worse than 95.32% of 513
companies
in the Drug Manufacturers industry
Industry Median: 1.92
vs ROCO:7762: 0.50
During the past 12 months, Pet Pharm Biotech Co's average Dividends Per Share Growth Rate was -53.20% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Pet Pharm Biotech Co (ROCO:7762) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Pet Pharm Biotech Co Dividend Yield % Related Terms
Pet Pharm Biotech Co Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Pet Pharm Biotech Co's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7762 vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Pet Pharm Biotech Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pet Pharm Biotech Co Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pet Pharm Biotech Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Pet Pharm Biotech Co's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Pet Pharm Biotech Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.250000
2026-07-20
2026-07-21
2026-08-21
Cash Dividend
annually
TWD:TWD 1.000000
TWD 0.088150
2025-08-25
2025-08-26
2025-10-14
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Pet Pharm Biotech Co's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pet Pharm Biotech Co (ROCO:7762) has a Dividend Yield % of 0.50% as of Jul. 21, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Pet Pharm Biotech Co and its competitors. This is 92% above median its historical median of 0.26. Over the past decade, Pet Pharm Biotech Co's Dividend Yield % has ranged from 0.13 to 0.50. According to the industry distribution chart, Pet Pharm Biotech Co ranks #489 out of 513 companies in the Drug Manufacturers industry, placing it in the top 95.3%.
Is Pet Pharm Biotech Co's Dividend Yield % too high?
Pet Pharm Biotech Co's current Dividend Yield % of 0.50% is 92% above median its 10-year median of 0.26. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 0.50. The Drug Manufacturers industry median Dividend Yield % is 1.92. Pet Pharm Biotech Co's value of 0.50% is 74% below this industry median. Based on the distribution chart, Pet Pharm Biotech Co ranks #489 out of 513 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pet Pharm Biotech Co has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Pet Pharm Biotech Co's Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Pet Pharm Biotech Co ranks #489 out of 513 companies for Dividend Yield %. This places Pet Pharm Biotech Co in the lower half of its industry. The industry median Dividend Yield % is 1.92. Pet Pharm Biotech Co's value of 0.50% is 74% below this benchmark. Historically, Pet Pharm Biotech Co's own Dividend Yield % has ranged from 0.13 to 0.50 over the past decade. While the company's 10-year median is 0.26 vs. the industry median of 1.92, Pet Pharm Biotech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.92, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pet Pharm Biotech Co's current Dividend Yield % of 0.50% is 74% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Pet Pharm Biotech Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pet Pharm Biotech Co's current Dividend Yield % is 0.50%, which is 92% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pet Pharm Biotech Co stock overvalued right now?
Pet Pharm Biotech Co (ROCO:7762) has a current Dividend Yield % of 0.50%. The current Dividend Yield % is 0.50%, which is 92% above median its 10-year median of 0.26 and 74% below the Drug Manufacturers industry median of 1.92. Pet Pharm Biotech Co's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Pet Pharm Biotech Co (ROCO:7762), the current Dividend Yield % is 0.50% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
19GF Score
Get the complete analysis for ROCO:7762
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7762 has been successfully added to your 
